021-51111890
购物车（）
sales@molnova.cn
Sarolaner
CAS No. 1398609-39-6
Sarolaner ( PF-6450567 )
产品货号. M23553 CAS No. 1398609-39-6
Sarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥786 | 有现货 |
|
| 10MG | ￥1442 | 有现货 |
|
| 25MG | ￥3062 | 有现货 |
|
| 50MG | ￥4601 | 有现货 |
|
| 100MG | ￥6602 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sarolaner
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Sarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
-
产品描述Sarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
-
同义词PF-6450567
-
通路Others
-
靶点Other Targets
-
受体LC80;LC100
-
研究领域——
-
适应症——
化学信息
-
CAS Number1398609-39-6
-
分子量581.4
-
分子式C23H18Cl2F4N2O5S
-
纯度>98% (HPLC)
-
溶解度DMSO : 290 mg/mL (498.83 mM; Need ultrasonic)
-
SMILESO=S(CC(N1CC2(OCC3=C2C=CC(C4=NO[C@](C(F)(F)F)(C5=CC(Cl)=C(F)C(Cl)=C5)C4)=C3)C1)=O)(C)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.McTier TL, et al. Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs. Vet Parasitol. 2016 May 30;222:3-11.
产品手册
关联产品
-
steviolbioside
Steviolbioside is a natural sweetener it presents notable inhibition on human hepatocarcinoma cell Hep3B human breast cancer cell MDA-MB-231 and human pancreatic cancer cell BxPC-3 thus steviolbioside could be a potential remedy for human breast cancer.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
HeE1-2Tyr
HeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. It significantly inhibits West Nile, Dengue and SARS-CoV-2 RdRps (IC50 of 27.6 μM) activity in vitro.
